LFWD · Lifeward Ltd. · Financials
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, the Company incurred a consolidated net loss of $22.3 million and, as of June 30, 2026, had an accumulated deficit in the total amount of $307.1 million. The Company's cash and cash equivalents as of June 30, 2026 totaled $9.4 million and the Company's negative operating cash flow for the six months ended June 30, 2026 was $9.7 million. The Company expects to continue to generate operating losses and negative operating cash flows in the foreseeable future and will require additional funding to support its planned operations. These conditions raise substantial doubt about the Company's ability to continue as a going concern. ... Accordingly, the Company has concluded that substantial doubt exists about its ability to continue as a going concern for at least 12 months from the date of issuance of these consolidated financial statements.”View the 10-Q filed Aug 14, 2026
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $21.82M | $22.03MG | $25.66MG | $13.85M | $5.51M | $5.97M | $4.39M | $4.87M | $6.55M | $7.75M | $5.87M | $3.75M | $3.95M | $1.59M | $972K | |
| — | -$312K | $643K | $1.35M | $0 | $0 | — | — | — | — | — | — | — | — | — | |
| $13.98M | $13.61M | $17.45M | $9.4M | $3.61M | $3.06M | $2.2M | $2.15M | $3.72M | $4.65M | $5.13M | $3.53M | $4.11M | $2.02M | $983K | |
| $7.85M | $8.43M | $8.22M | $4.45M | $1.91M | $2.9M | $2.19M | $2.73M | $2.83M | $3.1M | $736K | $214K | -$621K | -$429K | -$11K | |
| — | 38.25% | 32.01% | 32.14% | 34.57% | 48.66% | 49.83% | 55.94% | 43.16% | 40% | 12.54% | 5.71% | -15.72% | -27.02% | -1.13% | |
| $9.16M | $3.25M | $4.63M | $4.15M | $4.03M | $2.94M | $3.46M | $5.35M | $7.35M | $6.04M | $9.03M | $5.94M | $8.56M | $2.46M | $1.76M | |
| $13.06M | $13.88M | $17.95M | $13.92M | $9.84M | $6.99M | $5.75M | $6.17M | $7.9M | $11.36M | $13.96M | $13.06M | $7.39M | $4.09M | $2.33M | |
| $8.38M | $8.2M | $5.2M | $10M | $7.13M | $5.63M | $4.98M | $5.26M | $6.79M | $7.69M | $8.19M | $6.4M | $3.35M | $1.76M | $1.66M | |
| $93K | $0 | $3.35M | $1.61M | $0 | $0 | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | $642K | $696K | $438K | $111K | $92K | $61K | |
| $30.6M | $28.1M | $37.56M | $28.07M | $21.01M | $15.56M | $14.19M | $16.77M | $22.04M | $25.09M | $31.18M | $25.39M | $19.3M | $8.32M | $5.75M | |
| -$22.75M | -$19.67M | -$29.35M | -$23.61M | -$19.1M | -$12.66M | -$12M | -$14.05M | -$19.21M | -$21.99M | -$30.44M | -$25.17M | -$19.93M | -$8.75M | -$5.76M | |
| — | -89.29% | -114.36% | -170.43% | -346.62% | -212.12% | -273.25% | -288.28% | -293.57% | -283.66% | -518.67% | -672.02% | -504.3% | -550.69% | -592.49% | |
| — | — | — | — | — | — | — | — | — | -$21.35M | -$29.75M | -$24.74M | -$19.81M | -$8.65M | -$5.7M | |
| -$30.88M | -$19.97M | -$28.9M | -$22.15M | -$19.1M | -$12.64M | -$12.93M | -$15.54M | -$21.68M | -$24.6M | -$32.5M | -$25.36M | -$21.62M | -$12.16M | -$6.64M | |
| -$50K | -$55K | $43K | -$12K | $467K | $94K | $51K | $7000 | -$5000 | $119K | $3000 | $53K | $45K | $22K | $21K | |
| -$30.83M | -$19.91M | -$28.94M | -$22.13M | -$19.57M | -$12.74M | -$12.98M | -$15.55M | -$21.68M | -$24.72M | -$32.5M | -$25.42M | -$21.67M | -$12.18M | -$6.66M | |
| — | -90.38% | -112.78% | -159.76% | -355.09% | -213.48% | -295.38% | -319.13% | -331.17% | -318.81% | -553.81% | -678.46% | -548.42% | -766.81% | -684.98% | |
| — | — | — | — | -$19.57M | -$12.74M | -$12.98M | -$15.55M | -$21.68M | -$24.72M | -$32.5M | -$25.42M | -$23.9M | -$13.84M | -$7.66M | |
| USD/shares | -$15.44 | -$17.16 | -$39.96 | -$31.13 | -$26.40 | -$22.68 | -$68.88 | — | — | — | — | — | — | — | — |
| USD/shares | -$15.44 | -$17.16 | -$39.96 | -$31.13 | -$26.40 | -$22.68 | -$68.88 | — | — | — | — | — | — | — | — |
| shares | — | 1.16M | 724.27K | 710.94K | 742.6K | 570.66K | 187.68K | 68.61K | 17.53K | 9625.6786 | 156.88K | 144.23K | 44.84K | 2210.5714 | 2210.5714 |
| shares | — | 1.16M | 724.27K | 710.94K | 742.6K | 570.66K | 187.68K | 68.61K | 17.53K | 9625.6786 | 156.88K | 144.23K | 44.84K | 2210.5714 | 2210.5714 |
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2026-06-30 | USD 743,000 | 10-Q filed 2026-08-14 |
| Current portion of convertible notes payable | 2026-06-30 | USD 0 | 10-Q filed 2026-08-14 |
| Noncurrent convertible notes payable | 2026-06-30 | USD 4,432,000 | 10-Q filed 2026-08-14 |
| Noncurrent operating lease liabilities | 2026-06-30 | USD 1,813,000 | 10-Q filed 2026-08-14 |
| Other long-term debt | 2026-06-30 | USD 440,000 | 10-Q filed 2026-08-14 |
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 68 similar-size Medical Devices companies (of 156 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| United States | $13,237,000 | $14,425,000 | $7,636,000 | $2,303,000 | $2,519,000 | $1,746,000 |
| Germany | $4,014,000 | $4,422,000 | $2,704,000 | — | — | — |
| Europe | $2,907,000 | $5,124,000 | $2,340,000 | $3,057,000 | $3,381,000 | $2,631,000 |
| Rest of World | $1,416,000 | $867,000 | $787,000 | $36,000 | $6,000 | — |
| Asia Pacific | $460,000 | $825,000 | $387,000 | $115,000 | $60,000 | $8,000 |
| Africa | — | — | — | — | — | $2,000 |
| Latin America | — | — | — | — | — | $6,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Product | $17,165,000 | $19,920,000 | $10,681,000 | $4,175,000 | $4,916,000 |
| Service and Warranty | $3,088,000 | $3,186,000 | $2,140,000 | $477,000 | $517,000 |
| Lease of Products | $1,781,000 | $2,557,000 | $1,033,000 | — | — |